Recettore H3 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Recettore H3" in Italian language version.

refsWebsite

Global rank Italian rank

16nih.gov

4^th place

9^th place

9doi.org

2^nd place

7^th place

7oadoi.org

799^th place

22^nd place

5web.archive.org

1^st place

2archive.org

6^th place

8^th place

1ebi.ac.uk

5,849^th place

low place

archive.org

Bakker RA, Histamine H₃-receptor isoforms, in Inflamm. Res., vol. 53, n. 10, 2004, pp. 509–16, DOI:10.1007/s00011-004-1286-9, PMID 15597144.
Schlicker E, Betz R, Göthert M, Histamine H₃ receptor-mediated inhibition of serotonin release in the rat brain cortex, in Naunyn Schmiedebergs Arch. Pharmacol., vol. 337, n. 5, 1988, pp. 588–90, DOI:10.1007/BF00182737, PMID 3412497.

doi.org

dx.doi.org

Bakker RA, Histamine H₃-receptor isoforms, in Inflamm. Res., vol. 53, n. 10, 2004, pp. 509–16, DOI:10.1007/s00011-004-1286-9, PMID 15597144.
Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM, Cloning and expression of the mouse histamine H₃ receptor: evidence for multiple isoforms, in J. Neurochem., vol. 90, n. 6, 2004, pp. 1331–8, DOI:10.1111/j.1471-4159.2004.02606.x, PMID 15341517.
Attoub S, Moizo L, Sobhani I, Laigneau JP, Lewin MJ, Bado A, The H₃ receptor is involved in cholecystokinin inhibition of food intake in rats, in Life Sci., vol. 69, n. 4, giugno 2001, pp. 469–78, DOI:10.1016/S0024-3205(01)01138-9, PMID 11459437.
Arrang JM, Garbarg M, Schwartz JC, Auto-inhibition of brain histamine release mediated by a novel class (H₃) of histamine receptor, in Nature, vol. 302, n. 5911, 1983, pp. 832–7, DOI:10.1038/302832a0, PMID 6188956.
Schlicker E, Betz R, Göthert M, Histamine H₃ receptor-mediated inhibition of serotonin release in the rat brain cortex, in Naunyn Schmiedebergs Arch. Pharmacol., vol. 337, n. 5, 1988, pp. 588–90, DOI:10.1007/BF00182737, PMID 3412497.
Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW, Behavioral characterization of mice lacking histamine H₃ receptors, in Mol. Pharmacol., vol. 62, n. 2, 2002, pp. 389–97, DOI:10.1124/mol.62.2.389, PMID 12130692.
Passani MB, Lin JS, Hancock A, Crochet S, Blandina P, The histamine H₃ receptor as a novel therapeutic target for cognitive and sleep disorders, in Trends Pharmacol. Sci., vol. 25, n. 12, 2004, pp. 618–25, DOI:10.1016/j.tips.2004.10.003, PMID 15530639.
Medhurst SJ, Collins SD, Billinton A, Bingham S, Dalziel RG, Brass A, Roberts JC, Medhurst AD, Chessell IP, Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain., in Pain, vol. 138, n. 1, 2008, pp. 61–78, DOI:10.1016/j.pain.2007.11.006, PMID 18164820.
Leurs R, Bakker RA, Timmerman H, de Esch IJ, The histamine H₃ receptor: from gene cloning to H3 receptor drugs, in Nature reviews. Drug discovery, vol. 4, n. 2, 2005, pp. 107–20, DOI:10.1038/nrd1631, PMID 15665857.

ebi.ac.uk

InterPro: IPR003980 Histamine H3 receptor, su InterPro, European Bioinformatics Institute.

nih.gov

ncbi.nlm.nih.gov

West RE, Zweig A, Shih NY, Siegel MI, Egan RW, Clark MA, Identification of two H₃-histamine receptor subtypes (abstract), in Mol. Pharmacol., vol. 38, n. 5, 1990, pp. 610–3, PMID 2172771. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 21 novembre 2008).
Bakker RA, Histamine H₃-receptor isoforms, in Inflamm. Res., vol. 53, n. 10, 2004, pp. 509–16, DOI:10.1007/s00011-004-1286-9, PMID 15597144.
Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM, Cloning and expression of the mouse histamine H₃ receptor: evidence for multiple isoforms, in J. Neurochem., vol. 90, n. 6, 2004, pp. 1331–8, DOI:10.1111/j.1471-4159.2004.02606.x, PMID 15341517.
Attoub S, Moizo L, Sobhani I, Laigneau JP, Lewin MJ, Bado A, The H₃ receptor is involved in cholecystokinin inhibition of food intake in rats, in Life Sci., vol. 69, n. 4, giugno 2001, pp. 469–78, DOI:10.1016/S0024-3205(01)01138-9, PMID 11459437.
Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. Journal of Pharmacology and Experimental Therapeutics. 2005 Jul;314(1):271-81. PMID 15821027
Tedford CE, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Handley MK, Yates SL, Development of trans-2-(1H-imidazol-4-yl) cyclopropane derivatives as new high-affinity histamine H₃ receptor ligands (abstract), in J. Pharmacol. Exp. Ther., vol. 289, n. 2, 1999, pp. 1160–8, PMID 10215700. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 7 gennaio 2009).
Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. Biochemical Pharmacology. 2004 September 1;68(5):933-45. PMID 15294456
Arrang JM, Garbarg M, Schwartz JC, Auto-inhibition of brain histamine release mediated by a novel class (H₃) of histamine receptor, in Nature, vol. 302, n. 5911, 1983, pp. 832–7, DOI:10.1038/302832a0, PMID 6188956.
Schlicker E, Betz R, Göthert M, Histamine H₃ receptor-mediated inhibition of serotonin release in the rat brain cortex, in Naunyn Schmiedebergs Arch. Pharmacol., vol. 337, n. 5, 1988, pp. 588–90, DOI:10.1007/BF00182737, PMID 3412497.
Hatta E, Yasuda K, Levi R, Activation of histamine H₃ receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia (abstract), in J. Pharmacol. Exp. Ther., vol. 283, n. 2, 1997, pp. 494–500, PMID 9353362. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 30 giugno 2008).
Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG, Cloning and functional expression of the human histamine H₃ receptor (abstract), in Mol. Pharmacol., vol. 55, n. 6, 1999, pp. 1101–7, PMID 10347254. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 6 settembre 2008).
Levi R, Smith NC, Histamine H₃-receptors: a new frontier in myocardial ischemia (abstract), in J. Pharmacol. Exp. Ther., vol. 292, n. 3, 2000, pp. 825–30, PMID 10688593. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 2 dicembre 2008).
Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW, Behavioral characterization of mice lacking histamine H₃ receptors, in Mol. Pharmacol., vol. 62, n. 2, 2002, pp. 389–97, DOI:10.1124/mol.62.2.389, PMID 12130692.
Passani MB, Lin JS, Hancock A, Crochet S, Blandina P, The histamine H₃ receptor as a novel therapeutic target for cognitive and sleep disorders, in Trends Pharmacol. Sci., vol. 25, n. 12, 2004, pp. 618–25, DOI:10.1016/j.tips.2004.10.003, PMID 15530639.
Medhurst SJ, Collins SD, Billinton A, Bingham S, Dalziel RG, Brass A, Roberts JC, Medhurst AD, Chessell IP, Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain., in Pain, vol. 138, n. 1, 2008, pp. 61–78, DOI:10.1016/j.pain.2007.11.006, PMID 18164820.
Leurs R, Bakker RA, Timmerman H, de Esch IJ, The histamine H₃ receptor: from gene cloning to H3 receptor drugs, in Nature reviews. Drug discovery, vol. 4, n. 2, 2005, pp. 107–20, DOI:10.1038/nrd1631, PMID 15665857.

oadoi.org

Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM, Cloning and expression of the mouse histamine H₃ receptor: evidence for multiple isoforms, in J. Neurochem., vol. 90, n. 6, 2004, pp. 1331–8, DOI:10.1111/j.1471-4159.2004.02606.x, PMID 15341517.
Attoub S, Moizo L, Sobhani I, Laigneau JP, Lewin MJ, Bado A, The H₃ receptor is involved in cholecystokinin inhibition of food intake in rats, in Life Sci., vol. 69, n. 4, giugno 2001, pp. 469–78, DOI:10.1016/S0024-3205(01)01138-9, PMID 11459437.
Arrang JM, Garbarg M, Schwartz JC, Auto-inhibition of brain histamine release mediated by a novel class (H₃) of histamine receptor, in Nature, vol. 302, n. 5911, 1983, pp. 832–7, DOI:10.1038/302832a0, PMID 6188956.
Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW, Behavioral characterization of mice lacking histamine H₃ receptors, in Mol. Pharmacol., vol. 62, n. 2, 2002, pp. 389–97, DOI:10.1124/mol.62.2.389, PMID 12130692.
Passani MB, Lin JS, Hancock A, Crochet S, Blandina P, The histamine H₃ receptor as a novel therapeutic target for cognitive and sleep disorders, in Trends Pharmacol. Sci., vol. 25, n. 12, 2004, pp. 618–25, DOI:10.1016/j.tips.2004.10.003, PMID 15530639.
Medhurst SJ, Collins SD, Billinton A, Bingham S, Dalziel RG, Brass A, Roberts JC, Medhurst AD, Chessell IP, Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain., in Pain, vol. 138, n. 1, 2008, pp. 61–78, DOI:10.1016/j.pain.2007.11.006, PMID 18164820.
Leurs R, Bakker RA, Timmerman H, de Esch IJ, The histamine H₃ receptor: from gene cloning to H3 receptor drugs, in Nature reviews. Drug discovery, vol. 4, n. 2, 2005, pp. 107–20, DOI:10.1038/nrd1631, PMID 15665857.

web.archive.org

West RE, Zweig A, Shih NY, Siegel MI, Egan RW, Clark MA, Identification of two H₃-histamine receptor subtypes (abstract), in Mol. Pharmacol., vol. 38, n. 5, 1990, pp. 610–3, PMID 2172771. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 21 novembre 2008).
Tedford CE, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Handley MK, Yates SL, Development of trans-2-(1H-imidazol-4-yl) cyclopropane derivatives as new high-affinity histamine H₃ receptor ligands (abstract), in J. Pharmacol. Exp. Ther., vol. 289, n. 2, 1999, pp. 1160–8, PMID 10215700. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 7 gennaio 2009).
Hatta E, Yasuda K, Levi R, Activation of histamine H₃ receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia (abstract), in J. Pharmacol. Exp. Ther., vol. 283, n. 2, 1997, pp. 494–500, PMID 9353362. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 30 giugno 2008).
Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG, Cloning and functional expression of the human histamine H₃ receptor (abstract), in Mol. Pharmacol., vol. 55, n. 6, 1999, pp. 1101–7, PMID 10347254. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 6 settembre 2008).
Levi R, Smith NC, Histamine H₃-receptors: a new frontier in myocardial ischemia (abstract), in J. Pharmacol. Exp. Ther., vol. 292, n. 3, 2000, pp. 825–30, PMID 10688593. URL consultato il 24 dicembre 2013 (archiviato dall'url originale il 2 dicembre 2008).